or Try an Advanced Search...

    Technical Analysis for PRQR - ProQR Therapeutics B.V.

    Grade Last Price % Change Price Change
    D 1.91 -3.78% -0.08
    PRQR closed down 3.78 percent on Wednesday, May 15, 2024, on 72 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical PRQR trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Earnings Movers Other 0.00%
    BB Squeeze + Lower Band Touch Range Contraction 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    20 DMA Support Bullish -3.78%
    Bollinger Band Squeeze Range Contraction -3.78%
    Earnings Movers Other -3.78%
    Outside Day Range Expansion -3.78%
    Gapped Up Strength -3.78%
    Older End-of-Day Signals for PRQR ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Resistance about 14 hours ago
    Down 5% about 14 hours ago
    Down 3% about 14 hours ago
    Fell Below Lower Bollinger Band about 14 hours ago
    Fell Below Previous Day's Low about 14 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    PRQR Chart by TradingView
    Basic chart:

    Profile

    ProQR Therapeutics B.V., a biopharmaceutical company, is engaged in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. Its lead product candidate includes QR-010, a RNA-based oligonucleotide for the treatment of cystic fibrosis. The company was founded in 2012 and is headquartered in Leiden, the Netherlands.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cystic Fibrosis Oligonucleotide Regulus Therapeutics Alnylam Pharmaceuticals Genetic Disorder Therapeutic Gene Modulation Treatment Of Cystic Fibrosis

    Is PRQR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 13 Shareholders in ProQR Therapeutics (NASDAQ:PRQR) are in the red if they invested five years ago
    May 11 ProQR Therapeutics N.V. (PRQR) ASGCT Investor Webcast (Transcript)
    May 9 ProQR GAAP EPS of -€0.09, revenue of €4.45M
    May 9 ProQR Announces First Quarter 2024 Operating and Financial Results
    May 8 ProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer™ RNA Editing Program Targeting NTCP for Cholestatic Diseases
    Apr 23 ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024
    Apr 22 ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting
    Apr 19 ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio
    Mar 14 ProQR Therapeutics Full Year 2023 Earnings: Misses Expectations
    Mar 13 ProQR reports FY results
    See more PRQR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.29
    52 Week Low 1.11
    Average Volume 168,304
    200-Day Moving Average 1.80
    50-Day Moving Average 2.13
    20-Day Moving Average 1.98
    10-Day Moving Average 1.99
    Average True Range 0.13
    RSI (14) 38.65
    ADX 17.75
    +DI 16.72
    -DI 17.91
    Chandelier Exit (Long, 3 ATRs) 1.77
    Chandelier Exit (Short, 3 ATRs) 2.20
    Upper Bollinger Bands 2.06
    Lower Bollinger Band 1.90
    Percent B (%b) 0.06
    BandWidth 7.81
    MACD Line -0.04
    MACD Signal Line -0.04
    MACD Histogram 0.0032
    Fundamentals Value
    Market Cap 155.01 Million
    Num Shares 81.2 Million
    EPS -0.51
    Price-to-Earnings (P/E) Ratio -3.75
    Price-to-Sales 36.79
    Price-to-Book 3.58
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.08
    Resistance 3 (R3) 2.08 2.04 2.05
    Resistance 2 (R2) 2.04 1.99 2.03 2.04
    Resistance 1 (R1) 1.97 1.97 1.95 1.97 2.03
    Pivot Point 1.93 1.93 1.92 1.92 1.93
    Support 1 (S1) 1.86 1.88 1.84 1.86 1.79
    Support 2 (S2) 1.82 1.86 1.81 1.78
    Support 3 (S3) 1.75 1.82 1.77
    Support 4 (S4) 1.75